NCT01436656 2024-10-28A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant MelanomaPfizerPhase 1 Completed107 enrolled 49 charts
NCT03864042 2024-09-27Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid TumorsPfizerPhase 1 Completed56 enrolled 158 charts